BASILIXIMAB (SIMULECT®) IS SAFE AND EFFECTIVE IN COMBINATION WITH TRIPLE THERAPY OF NEORAL®, STEROIDS AND CELLCEPT® IN RENAL TRANSPLANT RECIPIENTS.
- 1 April 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 69 (8) , S260
- https://doi.org/10.1097/00007890-200004271-00572
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: